Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric Cancer
Clinical trial NCT04267549 · UNKNOWN
Trial details
- NCT number
- NCT04267549
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-01
- Primary completion
- 2022-12-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.